The Italian government explained that Australia is not in the account ‘At risk’ as there is a severe shortage of vaccines in the EU The vaccine is also very high compared to the share that AstraZeneca has given to Italy and the European Union.
–
The EU’s vaccination program is coming under heavy criticism. About delay Because they chose a representative to negotiate to buy the vaccine. Contrary to the UK where vaccinations are swift
They also had more problems when Astra Seneca announced in January that They had only 31 million doses of the vaccine delivered to the EU in the first quarter, or 40% of what was agreed, citing problems at a Belgian manufacturing facility. While manufacturing plants in England still produce the same proportion
This has seriously upset the European Union. Up to the announcement of the so-called export control measures The ‘transparency and authorization mechanism’ on Jan. 30, which could affect the delivery of vaccines from the EU to other countries. Like this is the case
– .
